You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Progressive Vestibular Schwannomas

Showing 1 - 25 of 5,051
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neurofibromatosis Type 2, Vestibular Schwannomas Trial in New York (Axitinib)

Completed
Has Results
  • Neurofibromatosis Type 2
  • Vestibular Schwannomas
  • New York, New York
    NYU Langone Medical Center
Nov 24, 2021

Neurofibromatosis 2, Progressive Vestibular Schwannoma (VS) Trial in United States (Crizotinib)

Active, not recruiting
  • Neurofibromatosis 2
  • Progressive Vestibular Schwannoma (VS)
  • Birmingham, Alabama
  • +16 more
Jan 3, 2023

Neurofibromatosis Type 2, Progressive Vestibular Schwannomas Trial in United States (Bevacizumab)

Completed
Has Results
  • Neurofibromatosis Type 2
  • Progressive Vestibular Schwannomas
  • Los Angeles, California
  • +11 more
Jan 26, 2021

Vestibular Schwannoma Trial in Milwaukee (procedure, radiation, other)

Not yet recruiting
  • Vestibular Schwannoma
  • Microsurgical resection of VS
  • +2 more
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Jan 18, 2023

Vestibular Schwannoma Trial in London (Probabilistic diffusion tensor tractography)

Recruiting
  • Vestibular Schwannoma
  • Probabilistic diffusion tensor tractography
  • London, United Kingdom
    King's College Hospital NHS Foundation Trust
Mar 29, 2022

MR Fingerprinting for Vestibular Schwannomas

Recruiting
  • Vestibular Schwannoma
  • MR Fingerprinting
  • Vienna, Austria
    Medical University of Vienna
Apr 20, 2021

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Recruiting
  • Neurofibromatosis 2
  • Bevacizumab Zirconium Zr-89
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Jan 5, 2023

Vestibular Schwannoma, NF2, Neurofibromatosis 2 Trial in United States (lapatinib)

Completed
Has Results
  • Vestibular Schwannoma
  • +4 more
  • Los Angeles, California
  • +6 more
Dec 22, 2020

Vestibular Schwannoma Trial in Vienna (Triamcinolone Acetonide 40mg/mL)

Recruiting
  • Vestibular Schwannoma
  • Triamcinolone Acetonide 40mg/mL
  • Vienna, Austria
    Medical University of Vienna (AKH)
Dec 7, 2020

Neurofibromatosis Type 2, Vestibular Schwannomas, Meningiomas Trial in New York (RAD001)

Completed
  • Neurofibromatosis Type 2
  • +2 more
  • New York, New York
    New York University School of Medicine
May 12, 2020

Natural History Study of Patients With Neurofibromatosis Type 2

Recruiting
  • Neurofibromatosis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Vestibular Schwannoma Trial in Rochester (Omega-3, Placebo)

    Recruiting
    • Vestibular Schwannoma
    • Omega-3
    • Placebo
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 11, 2022

    Vestibular Schwannoma Trial in Tuebingen (Remote ischemic preconditioning, Sham-control)

    Not yet recruiting
    • Vestibular Schwannoma
    • Remote ischemic preconditioning
    • Sham-control
    • Tuebingen, Germany
      University Hospital Tuebingen
    Sep 30, 2022

    Vestibular Schwannoma, Neurofibromatosis Type 2 Trial in Beijing (Icotinib)

    Completed
    • Vestibular Schwannoma
    • Neurofibromatosis Type 2
    • Beijing, Beijing, China
    • +1 more
    Sep 8, 2021

    Vestibular Schwannoma Trial in Toulouse (gammaknife radiosurgery)

    Recruiting
    • Vestibular Schwannoma
    • gammaknife radiosurgery
    • Toulouse, France
      CHU Toulouse
    Jul 7, 2021

    Vestibular Schwannoma Trial in Bergen (gamma knife radiosurgery)

    Completed
    • Vestibular Schwannoma
    • gamma knife radiosurgery
    • Bergen, Norway
      Haukeland Unviersity Hospital
    Oct 19, 2022

    Vestibular Schwannoma, Acoustic Neuroma, Sensorineural Hearing Loss Trial in Saint Louis (Auditory Nerve Test System)

    Active, not recruiting
    • Vestibular Schwannoma
    • +7 more
    • Auditory Nerve Test System
    • Saint Louis, Missouri
      Washington University
    Dec 8, 2022

    Sporadic Acoustic Neuromas, Useful Hearing Trial in Milano (Radiosurgery)

    Active, not recruiting
    • Sporadic Acoustic Neuromas
    • Useful Hearing
    • Radiosurgery
    • Milano, Mi, Italy
      Istittuto Nazionale Neurologico Carlo Besta
    Feb 18, 2021

    Acute Peripheral Vestibulopathy Following Surgical Procedure Trial in Prague (Prehabituation, 3D optokinetic stimulation in

    Recruiting
    • Acute Peripheral Vestibulopathy Following Surgical Procedure
    • Prehabituation
    • +2 more
    • Prague, Czechia
      Department of Otorhinolaryngology and Head and Neck Surgery, 1st
    Oct 10, 2022

    ed in Chronic Obstructive Pulmonary Disease Patients

    Not yet recruiting
    • Vestibular Disorder
    • Respiratory Assessment
    • +2 more
    • (no location specified)
    Dec 1, 2022

    Vestibular Schwannoma Trial in Stockholm (Initial Gamma knife radiosurgery)

    Active, not recruiting
    • Vestibular Schwannoma
    • Initial Gamma knife radiosurgery
    • Stockholm, Sweden
      Department of Neurosurgery, Karolinska univeristy hospital
    Apr 5, 2022

    Healthy Aging Trial in Columbus (Vestibular Perceptual Learning, Placebo Intervention)

    Not yet recruiting
    • Healthy Aging
    • Vestibular Perceptual Learning
    • Placebo Intervention
    • Columbus, Ohio
      The Ohio State University Wexner Medical Center
    Apr 5, 2023

    Neurofibromatosis Type 2, Neuroma, Acoustic Trial in Los Angeles (RAD001, everolimus)

    Active, not recruiting
    • Neurofibromatosis Type 2
    • Neuroma, Acoustic
    • RAD001, everolimus
    • Los Angeles, California
      University of California Los Angeles
    Mar 2, 2022

    Vestibular Schwannoma Trial in Vienna (NiMODipine Injectable Solution, Placebo)

    Recruiting
    • Vestibular Schwannoma
    • NiMODipine Injectable Solution
    • Placebo
    • Vienna, Austria
      Medical University of Vienna
    Aug 23, 2022

    Vestibular Disease Trial in Rochester (Heading direction adaptation)

    Recruiting
    • Vestibular Disease
    • Heading direction adaptation
    • Rochester, New York
      University of Rochester Medical Center
    Nov 2, 2021